Vaccitech plc
VACC · NASDAQ
12/31/2024 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $124 | $88 | $288 | $111 |
| - Cash | $111 | $194 | $214 | $43 |
| + Debt | $12 | $9 | $7 | $46 |
| Enterprise Value | $25 | -$98 | $81 | $115 |
| Revenue | $15 | $45 | $0 | $5 |
| % Growth | -66.5% | 16,580.2% | -94.4% | – |
| Gross Profit | $0 | $2 | -$20 | -$10 |
| % Margin | 0% | 5.3% | -7,501.1% | -198.5% |
| EBITDA | $1 | $5 | -$45 | -$17 |
| % Margin | 7.9% | 11.6% | -16,873.5% | -342.7% |
| Net Income | -$61 | $5 | -$51 | -$18 |
| % Margin | -408% | 11.9% | -19,071.6% | -372% |
| EPS Diluted | -1.55 | 0.14 | -1.97 | -2.27 |
| % Growth | -1,207.1% | 107.1% | 13.2% | – |
| Operating Cash Flow | -$29 | -$14 | -$33 | -$11 |
| Capital Expenditures | -$1 | -$6 | -$1 | -$0 |
| Free Cash Flow | -$30 | -$21 | -$34 | -$11 |